Play Live Radio
Next Up:
Available On Air Stations

FDA Approves Artificial Pancreas for Diabetes Treatment

Boris Kovatchev, wearing a tan suede jacket and blue striped shirt, stands in a hospital hallway.
Boris Kovatchev, Director, UVA Center for Diabetes Technology (Photo: Dan Addison, University of Virginia)

The Food and Drug Administration approved a new way to treat Type 1 diabetes, based on research from the University of Virginia Center for Diabetes Technology. It’s an artificial pancreas system, which automatically monitors and regulates blood sugar levels.

Type 1 diabetes usually develops in childhood.  Treatment involves taking blood samples and injecting insulin with a needle or an insulin pump.  

 But the University of Virginia has developed an automated glucose-control system they say it’s easier, safer and less painful.

 Boris Kovatchev:  People with diabetes don’t have to do finger-sticks anymore

 Boris Kovatchev is Director of the UVA Center for Diabetes Technology

 Kovatchev:  They don’t have to calculate insulin amounts by themselves and they don’t have to use insulin injections.

The device, called Control IQ, has a sensor, insulin pump and smart control algorithm.  The manufacturer expects to begin shipping it at the end of the month.


Related Stories